Webinar Overview
TIO, also known as oncogenic osteomalacia, is a rare paraneoplastic syndrome caused by unregulated production of FGF23 by a tumor. Despite the biochemical hallmarks (e.g., elevated FGF23), the diagnosis of TIO is often elusive due to lack of knowledge or failure to investigate serum phosphate and FGF23 levels, and the nonspecific symptoms of TIO (i.e.,muscle weakness, bone pain, and pathologic fractures). This free certified CME/CE webinar features expert faculty from the National Institutes of Health who review case-based presentations of TIO symptoms.
PLUS: Live Q&A panel discussion with faculty at the end of each broadcast
Michael Collins, MD
Senior Investigator
Chief, Skeletal Disorders and Mineral Homeostasis Section
National Institute of Dental and Craniofacial Research
Director, Career Development and Research Training
NIH Interinstitute Endocrine Training Program
National Institutes of Health
Bethesda, MD
Iris Hartley, MD
Clinical Investigator, Skeletal Disorders and
Mineral Homeostasis Section
National Institute of Dental and Craniofacial Research
Faculty, Inter-institute Endocrine Training Program
National Institutes of Health
Bethesda, MD